Showing results (1-10 of 20) with videos related to
Sort By:
Pageof 2
Journal of Managed Care Pharmacy : JMCP|November 14, 2008
Use of erythropoiesis-stimulating agents among chemotherapy patients with hemoglobin exceeding 12 grams per deciliterBeth L Nordstrom, Weixiu Luo, Kathy Fraeman, et al.International Journal of Hypertension|January 24, 2014
Incidence of new-onset hypertension in cancer patients: a retrospective cohort studyKathy H Fraeman, Beth L Nordstrom, Weixiu Luo, et al.American Journal of Clinical Pathology|March 17, 2010
Presence of tumor-infiltrating lymphocytes and a dominant nodule within primary melanoma are prognostic factors for relapse-free survival of patients with thick (t4) primary melanoma: pathologic analysis of the e1690 and e1694 intergroup trialsUma N M Rao, Sandra J Lee, Weixiu Luo, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 2007
Phase II study of uracil-tegafur with leucovorin in elderly (> or = 75 years old) patients with colorectal cancer: ECOG 1299Howard S Hochster, Weixiu Luo, Elizabeta C Popa, et al.Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|June 2, 2023
Emerging Adult and Caregiver Psychosocial Experiences with Severe Hypoglycemic Events and the Perceived Impact of Nasal Glucagon: A Cross-Sectional StudyCaitlin S Kelly, Huyen Nguyen, Weixiu Luo, et al.Clinical Therapeutics|January 27, 2009
Adherence to guidelines for use of erythropoiesis-stimulating agents in patients with chemotherapy-induced anemia: results of a retrospective study of an electronic medical-records database in the United States, 2002-2006Weixiu Luo, Beth L Nordstrom, Kathy Fraeman, et al.International Journal of Radiation Oncology, Biology, Physics|February 6, 2007
Variability among breast radiation oncologists in delineation of the postsurgical lumpectomy cavityDaniel M Landis, Weixiu Luo, Jun Song, et al.JAMA Oncology|October 11, 2019
Assessment of Combined Nivolumab and Bevacizumab in Relapsed Ovarian Cancer: A Phase 2 Clinical TrialJoyce F Liu, Christina Herold, Kathryn P Gray, et al.International Journal of Cancer|November 13, 2019
Phase II, 2-stage, 2-arm, PIK3CA mutation stratified trial of MK-2206 in recurrent endometrial cancerAndrea P Myers, Panagiotis A Konstantinopoulos, William T Barry, et al.The Lancet. Oncology|September 15, 2014
Combination cediranib and olaparib versus olaparib alone for women with recurrent platinum-sensitive ovarian cancer: a randomised phase 2 studyJoyce F Liu, William T Barry, Michael Birrer, et al.Pageof 2